Clinical Trial Update: Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047) [Phase 3]

View source ↗

Summary

A Phase III trial evaluating chemoradiotherapy with or without pembrolizumab for locally advanced cervical cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Uterine Cervical Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2026-01-05